Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 25 March 2008
Vol. 1, Issue 12, p. pt2
[DOI: 10.1126/stke.112pt2]

PRESENTATIONS

In Vivo Imaging of T Cell Priming

Sarah E. Henrickson1, Thorsten R. Mempel1, Irina B. Mazo1, Bai Liu2, Maxim N. Artyomov3, Huan Zheng4, Antonio Peixoto1, Michael Flynn1, Balimkiz Senman1, Tobias Junt1, Hing C. Wong2, Arup K. Chakraborty3,4,5, and Ulrich H. von Andrian1*

1Department of Pathology and the Immune Disease Institute, Harvard Medical School, Boston, MA 02115, USA.
2Altor BioScience Corporation, 2810 North Commerce Parkway, Miramar, FL 33025, USA.
3Department of Chemical Engineering, Massachusetts Institute of Technology (MIT), 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
4Department of Chemistry, MIT, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
5Department of Biological Engineering, MIT, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

A presentation from the 11th Joint Meeting of the Signal Transduction Society (STS), Signal Transduction: Receptors, Mediators and Genes, Weimar, Germany, 1 to 3 November 2007.

Abstract: The rules by which naïve T cells decide whether and how to respond to antigenic stimuli are incompletely understood. Using multiphoton intravital microscopy (MP-IVM) in lymph nodes (LNs), we have shown that CD8+ T cells are primed by antigen-presenting dendritic cells (DCs) in three consecutive phases. During phase one, T cells undergo brief serial contacts with many DCs for several hours after homing into the LNs. Subsequently, during phase two, T cells engage in prolonged stable interactions with DCs. Finally, in the third phase, T cells return to transient interactions with DCs as they begin to proliferate and eventually leave the LNs. We have examined the influence of antigen dose on the duration of phase one by systematically varying both the number of cognate peptide–major histocompatability (pMHC) complexes per DC and the density of cognate pMHC complex–presenting DCs per LN. The duration of phase one and the kinetics of CD8+ T cell activation were inversely correlated with both parameters. Very few pMHC complexes were needed for full T cell activation and effector differentiation. Furthermore, there was a sharp threshold of antigen dose below which T cells did not transition to phase two but continued to migrate until they exited the LN, unactivated. The stability of peptide binding to MHC was a critical determinant of this threshold antigen dose in vivo. Our results suggest an integrative mechanism that allows T cells to reach an informed decision about whether to respond, based on the overall antigen dose encountered.

*Presenter and corresponding author. E-mail, uva{at}hms.harvard.edu

Citation: S. E. Henrickson, T. R. Mempel, I. B. Mazo, B. Liu, M. N. Artyomov, H. Zheng, A. Peixoto, M. Flynn, B. Senman, T. Junt, H. C. Wong, A. K. Chakraborty, U. H. von Andrian, In Vivo Imaging of T Cell Priming. Sci. Signal. 1, pt2 (2008).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Real-time differential labeling of blood, interstitium, and lymphatic and single-field analysis of vasculature dynamics in vivo.
G. Sarkisyan, S. M. Cahalan, P. J. Gonzalez-Cabrera, N. B. Leaf, and H. Rosen (2012)
Am J Physiol Cell Physiol 302, C1460-C1468
   Abstract »    Full Text »    PDF »
High-resolution, noninvasive longitudinal live imaging of immune responses.
M. H. Abdulreda, G. Faleo, R. D. Molano, M. Lopez-Cabezas, J. Molina, Y. Tan, O. A. R. Echeverria, E. Zahr-Akrawi, R. Rodriguez-Diaz, P. K. Edlund, et al. (2011)
PNAS 108, 12863-12868
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882